Approval · Notice of Compliance 3081 · 2004
RAPAMUNE: Notice of Compliance 3081
Issued May 28, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3081
- Date
- May 28, 2004
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to dosage regimen to include rapamune maintenance regimen
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | Not yet assigned | — |